#AHA2025 #Lipidology #AFib #PrecisionMedicine To view or add a comment, sign in Outcomes of Alprostadil As an Adjuvant Therapy with Indirect Angiosomal Revascularization in Patients with Critical Limb Ischemia after Failure of Direct Revascularization This study evaluated the effectiveness of alprostadil (PGE1) as an adjuvant therapy following indirect revascularization (IR) in patients with critical limb ischemia (CLI) who failed direct revascularization (DR)
In elderly patients with T2DM, GLP-1RAs have been shown to have the potential not only to control glycemia, but also to improve cognitive function and gait disorders [35]
A 2025 study of more than 5,000 older adults found that a poor sense of smell is associated with an increased risk of developing heart disease within four years
Jonathan Hunt-Glassman's LinkedIn post states, "We recently eclipsed 50,000 members served, but we're not stopping until everyone who needs it has access to safe, effective medication that can help them drink less or quit
improvement of the lipid profile, inflammation, oxidative stress, endothelial function, and blood pressure